Hypothesis: Exertional Heat Stroke-Induced Myopathy and Genetically Inherited Malignant Hyperthermia Represent the Same Disorder, the Human Stress Syndrome

Cell Biochemistry and Biophysics

Volumn 70, Issue 2, 2014, Pages 1325-1329

  Zhao, Xuesheng ^a,b   Song, Qing ^b   Gao, Yan ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Exertional heat stroke; Hypothesis; Stress syndrome

Indexed keywords

ADRENERGIC SYSTEM; ANIMAL; COMPLICATION; DISEASE PREDISPOSITION; EXERCISE; GENETICS; HEAT STROKE; HUMAN; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUSCULAR DISEASES; MUTATION; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; PHYSIOLOGY; PIG; SWINE DISEASE;

ANIMALS; DISEASE SUSCEPTIBILITY; HEAT STROKE; HUMANS; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUSCULAR DISEASES; MUTATION; PHYSICAL EXERTION; STRESS, PHYSIOLOGICAL; SWINE; SWINE DISEASES; SYMPATHETIC NERVOUS SYSTEM;

EID: 84964313478     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-014-0059-5     Document Type: Article

References (28)

1. Nelson, T. E., & Flewellen, E. H. (1983). The malignant hyperthermia syndrome. The New England Journal of Medicine,309, 416–418.
2. Gillard, E. F., Otsu, K., Fujii, J., Khanna, V. K., De Leon, S., Derdemezi, J., et al. (1991). A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics,11, 751–755.
3. Hopkins, P. M. (2000). Malignant hyperthermia: Advances in clinical management and diagnosis. British Journal of Anaesthesia,85(1), 118–128.
4. Davis, M., Brown, R., Dickson, A., Horton, H., James, D., Laing, N., et al. (2002). Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. British Journal of Anaesthesia,88, 508–515.
5. Gronert, G. A., Tobin, J. R., & Muldoon, S. (2011). Malignant hyperthermia: Human stress triggering. Biochimica et Biophysica Acta,1813, 2191–2192.
6. ® [Internet]. Seattle, WA: University of Washington. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1146/ [rosenberg et al, 2013] http://www.ncbi.nlm.nih.gov/books/NBK1146/. Accessed 31 Jan 2013.
7. Bouchama, A., & Knochel, J. P. (2002). The New England Journal of Medicine. New England Journal of Medicine,346, 1979–1988.
8. Carsana, A. (2013). Exercise-induced rhabdomyolysis and stress-induced malignant hyperthermia events, association with malignant hyperthermia susceptibility, and RYR1 gene sequence variations. The Scientific World Journal. Article ID 531465 (6 pp). doi:10.1155/2013/531465
9. Capacchione, J. F., & Muldoon, S. M. (2009). The relationship between exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia. Anesthesia and Analgesia,109, 1065–1069.
10. Wingard, D. W. (1974). Malignant hyperthermia: A human stress syndrome? Lancet,2, 1450–1451.
11. Fujii, J., Otsu, K., Zorzato, F., De Leon, S., Khanna, V. K., Weiler, J. E., et al. (1991). Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science,253(5018), 448–451.
12. Harrison, G. G. (1975). Control of the malignant hyperpyrexic syndrome in MHS swine by dantrolene sodium. British Journal of Anaesthesia,47, 62–65.
13. Treves, S., Jungbluth, H., Muntoni, F., et al. (2008). Congenital muscle disorders with cores: The ryanodine receptor calcium channel paradigm. Current Opinion in Pharmacology,8, 319–326.
14. Treves, S., Anderson, A. A., Ducreux, S., Divet, A., Bleunven, C., Grasso, C., et al. (2005). Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders. Neuromuscular Disorders,15(9), 577–587.
15. Campbell, I. T., Ellis, F. R., Evans, R. T., et al. (1983). Studies of body temperature, blood lactate, cortisol and free fatty acid levels during exercise in human subjects susceptible to malignant hyperpyrexia. Acta Anaesthesiologica Scandinavica,27, 349–355.
16. Tobin, J. R., Jason, D. R., Challa, V. R., et al. (2001). Malignant hyperthermia and apparent heat stroke. JAMA,286, 168–169.
17. Nishio, H., Sato, T., Fukunishi, S., et al. (2009). Identification of malignant hyperthermia-susceptible ryanodine receptor type 1 gene (RYR1) mutations in a child who died in a car after exposure to a high environmental temperature. Legal Medicine,11, 142–143.
18. Sambuughin, N., Capacchione, J., Blokhin, A., Bayarsaikhan, M., Bina, S., & Muldoon, S. (2009). The ryanodine receptor type 1 gene variants in African American men with exertional rhabdomyolysis and malignant hyperthermia susceptibility. Clinical Genetics,76, 564–568.
19. Wappler, F., Fiege, M., Steinfath, M., et al. (2001). Evidence for susceptibility to malignant hyperthermia in patients with exercise-induced rhabdomyolysis. Anesthesiology,94, 95–100.
20. Thomas, J., & Crowhurst, T. (2013). Exertional heat stroke, rhabdomyolysis and susceptibility to malignant hyperthermia. Journal of Internal Medicine,43(9), 1035–1038.
21. Hackl, W., Winkler, M., Mauritz, W., et al. (1991). Muscle biopsy for diagnosis of malignant hyperthermia susceptibility in two patients with severe exercise-induced myolysis. British Journal of Anaesthesia,66, 138–140.
22. Köchling, A., Wappler, F., Winkler, G., et al. (1998). Rhabdomyolysis following severe physical exercise in a patient with predisposition to malignant hyperthermia. Anaesthesia and Intensive Care,26, 315–318.
23. Ogletree, J. W., Antognini, J. F., & Gronert, G. A. (1996). Postexercise muscle cramping associated with positive malignant hyperthermia contracture testing. American Journal of Sports Medicine,24, 49–51.
24. Bendahan, D., Kozak-Ribbens, G., Confort-Gouny, S., et al. (2001). A noninvasive investigation of muscle energetics supports similarities between exertional heat stroke and malignant hyperthermia. Anesthesia and Analgesia,93, 683–689.
25. Wappler, F., Fiege, M., Antz, M., et al. (2000). Hemodynamic and metabolic alterations in response to graded exercise in a patient susceptible to malignant hyperthermia. Anesthesiology,92, 268–272.
26. Nelson, T. E., & Flewellen, E. H. (1983). Current concepts. The malignant hyperthermia syndrome. New England Journal of Medicine,309(7), 416–418.
27. Brady, J. E., Sun, L. S., Rosenberg, H., et al. (2009). Prevalence of malignant hyperthermia due to anesthesia in New York State, 2001–2005. Anesthesia and Analgesia,109(4), 1162–1166.
28. Muldoon, S., Deuster, P., Voelkel, M., Capacchione, J., & Bunger, R. (2008). Exertional heat illness, exertional rhabdomyolysis, and malignant hyperthermia: Is there a link? Current Sports Medicine Reports,7(2), 74–80.